Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001019687-08-005502

Director bought 1,250,000 shares at $0.13 ($162,500)

From the SEC's structured data for this filing

Trades in this filing

Berg Jeffrey Alan · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2008-12-12 Purchase : show line 1 in the form +1,250,000 $0.13 $162,500 5,469,600 I
Open-market purchases · 1,250,000 sh · avg $0.13 · $162,500
Loading xslF345X03/edgar.xml…